mibefradil has been researched along with Cancer of Skin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bahí, N; Cantí, C; Das, A; Herreros, J; Martí, RM; Matias-Guiu, X; Pamplona, R; Pushparaj, C; Sorolla, A; Vilella, R | 1 |
Bigner, DD; Friedman, HS; Gray, LA; Keir, ST; Reardon, DA | 1 |
2 other study(ies) available for mibefradil and Cancer of Skin
Article | Year |
---|---|
Functional expression of voltage-gated calcium channels in human melanoma.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Calcium; Calcium Channel Blockers; Calcium Channels; Cell Cycle; Cell Hypoxia; Cell Line, Tumor; Cell Lineage; Cell Proliferation; Cell Survival; Flow Cytometry; Fura-2; Gene Expression Regulation, Neoplastic; Humans; Manganese; Melanocytes; Melanoma; Mibefradil; Molecular Imaging; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction; Skin Neoplasms; Up-Regulation | 2012 |
Mibefradil, a novel therapy for glioblastoma multiforme: cell cycle synchronization and interlaced therapy in a murine model.
Topics: Animals; Antineoplastic Agents, Alkylating; Brain Neoplasms; Calcium Channel Blockers; Cell Cycle; Dacarbazine; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Glioblastoma; Humans; Kaplan-Meier Estimate; Mibefradil; Mice; Neoplasm Transplantation; Skin Neoplasms; Temozolomide; Time Factors; Xenograft Model Antitumor Assays | 2013 |